Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 010942

Expand all

SPARINE (PROMAZINE HYDROCHLORIDE)
30MG/ML
Marketing Status: Discontinued

Active Ingredient: PROMAZINE HYDROCHLORIDE
Proprietary Name: SPARINE
Dosage Form; Route of Administration: CONCENTRATE; ORAL
Strength: 30MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010942
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status:  Discontinued
Patent and Exclusivity Information

SPARINE (PROMAZINE HYDROCHLORIDE)
100MG/ML
Marketing Status: Discontinued

Active Ingredient: PROMAZINE HYDROCHLORIDE
Proprietary Name: SPARINE
Dosage Form; Route of Administration: CONCENTRATE; ORAL
Strength: 100MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010942
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status:  Discontinued
Patent and Exclusivity Information

SPARINE (PROMAZINE HYDROCHLORIDE)
10MG/5ML
Marketing Status: Discontinued

Active Ingredient: PROMAZINE HYDROCHLORIDE
Proprietary Name: SPARINE
Dosage Form; Route of Administration: SYRUP; ORAL
Strength: 10MG/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010942
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status:  Discontinued
Patent and Exclusivity Information